| 1493 |
National Cancer Institute |
Html |
en |
Oropharyngeal Cancer Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of oropharyngeal cancer. |
| neck radiotherapy | 0.359364 |
| locally advanced head | 0.471621 |
| Engl J Med | 0.53665 |
| American Cancer Society | 0.443811 |
| well-lateralized oropharyngeal cancer | 0.401103 |
| neck radiation therapy | 0.384516 |
| Int J Radiat | 0.508851 |
| neck cancer patients | 0.486158 |
| squamous cell cancer | 0.411067 |
| Radiat Oncol Biol | 0.753309 |
| DeVita VT Jr | 0.383261 |
| Natl Cancer Inst | 0.447951 |
| neck cancers | 0.433823 |
| Clin Cancer Res | 0.390283 |
| radiation therapy | 0.610067 |
| human papillomavirus | 0.44587 |
| smoking-related oropharyngeal cancer | 0.443579 |
| HPV-positive oropharyngeal cancer | 0.448716 |
| et al. | 0.570118 |
| Mendenhall WM | 0.369324 |
| Cancer Genet Cytogenet | 0.359903 |
| Head Neck | 0.484421 |
| index nonoropharyngeal cancer | 0.350094 |
| Oropharyngeal tumors | 0.352557 |
| index oropharyngeal SCC | 0.386084 |
|
| neck SCC | 0.359598 |
| oropharyngeal cancers | 0.476599 |
| HPV-positive oropharyngeal cancers | 0.469127 |
| anterior tonsillar pillar | 0.378606 |
| Cancer Epidemiol Biomarkers | 0.378376 |
| neck squamous cell | 0.377126 |
| head | 0.534685 |
| PUBMED Abstract | 0.462256 |
| early-stage oropharyngeal cancer | 0.392101 |
| Otolaryngol Head Neck | 0.404239 |
| index oropharyngeal cancers | 0.372661 |
| -positive oropharyngeal cancers | 0.363257 |
| neck retinoid chemoprevention | 0.355793 |
| Abstract | 0.60039 |
| Clin Oncol | 0.357598 |
| Oncol Biol Phys | 0.772447 |
| squamous cell carcinomas | 0.385763 |
| primary tumor | 0.372966 |
| field cancerization | 0.370643 |
| neck cancer | 0.957961 |
| neck tumors | 0.340144 |
| oropharyngeal cancer | 0.807108 |
| oropharyngeal SCC | 0.391565 |
| oropharyngeal cancer incidence | 0.417437 |
|
CLICK HERE |
| 1561 |
National Cancer Institute |
Html |
en |
Hairy Cell Leukemia Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of hairy cell leukemia. |
| red blood cells | 0.288652 |
| cancer treatment | 0.275128 |
| following PDQ summaries | 0.252637 |
| PDQ cancer information | 0.3118 |
| clinical trial search | 0.280542 |
| white blood cells | 0.33408 |
| clinical trials | 0.546221 |
| mature blood cells | 0.288256 |
| Natural killer cells | 0.259899 |
| bone marrow cell | 0.248193 |
| cancer information summary | 0.285589 |
| clinical trial | 0.391443 |
| patients | 0.269231 |
| blood cells | 0.357276 |
| earlier clinical trials | 0.248664 |
| Biologic therapy | 0.261621 |
| refractory hairy cell | 0.259547 |
| treatment clinical trial | 0.258654 |
| PDQ Adult Treatment | 0.254235 |
| Cell Leukemia Treatment | 0.279873 |
| NCI PDQ cancer | 0.262149 |
| Treatment Editorial Board | 0.264015 |
| treatment | 0.372653 |
| myeloid stem cell | 0.267967 |
|
| blood stem cell | 0.256899 |
| progressive hairy cell | 0.304412 |
| new cancer treatments | 0.249482 |
| NCI-supported cancer | 0.251402 |
| cancer cells | 0.341635 |
| lymphoid stem cell | 0.268394 |
| laboratory test | 0.252149 |
| Cancer Information Service | 0.24796 |
| specific cancer cells | 0.268675 |
| treatment clinical trials | 0.277379 |
| blood stem cells | 0.287064 |
| National Cancer Institute | 0.286081 |
| normal cells | 0.252914 |
| new treatment | 0.277346 |
| hairy cell leukemia | 0.902024 |
| bone marrow | 0.339709 |
| healthy blood cells | 0.262175 |
| untreated hairy cell | 0.280676 |
| cancer clinical trials | 0.292375 |
| cancer information summaries | 0.250228 |
| comprehensive cancer information | 0.249864 |
| cancer | 0.442493 |
| standard treatment | 0.257771 |
| leukemia cells | 0.29846 |
|
CLICK HERE |
| 1562 |
National Cancer Institute |
Html |
en |
Hypopharyngeal Cancer Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of hypopharyngeal cancer. |
| cancer treatment | 0.321266 |
| high-dose radiation therapy | 0.323579 |
| centimeters | 0.269921 |
| cancer spreads | 0.270417 |
| malignant tumor cells | 0.281954 |
| body | 0.305644 |
| chemotherapy | 0.290118 |
| PDQ cancer information | 0.346817 |
| stage III hypopharyngeal | 0.274417 |
| clinical trial search | 0.347149 |
| clinical trials | 0.698171 |
| hypopharynx | 0.280224 |
| cancer information summary | 0.319294 |
| metastatic hypopharyngeal cancer | 0.310093 |
| clinical trial | 0.551798 |
| Recurrent hypopharyngeal cancer | 0.306668 |
| patients | 0.317052 |
| stage IV hypopharyngeal | 0.274937 |
| nearby soft tissue | 0.271159 |
| treatment clinical trial | 0.275593 |
| NCI PDQ cancer | 0.283768 |
| radiation therapy | 0.705932 |
| Treatment Editorial Board | 0.281401 |
| General information | 0.289657 |
| hypopharyngeal cancer | 0.722179 |
|
| general cancer information | 0.275426 |
| treatment | 0.442202 |
| new cancer treatments | 0.272872 |
| NCI-supported cancer | 0.296123 |
| cancer cells | 0.361641 |
| Cancer Information Service | 0.276024 |
| patient | 0.26688 |
| lymph nodes | 0.350794 |
| treatment clinical trials | 0.300384 |
| National Cancer Institute | 0.364736 |
| swollen lymph nodes | 0.277694 |
| new treatment | 0.302418 |
| External radiation therapy | 0.314938 |
| neck | 0.309398 |
| cancer research process | 0.269057 |
| cancer clinical trials | 0.358746 |
| stage | 0.310003 |
| neck cancer | 0.286172 |
| lymph node | 0.322344 |
| cancer information summaries | 0.27414 |
| comprehensive cancer information | 0.274558 |
| cancer | 0.901171 |
| standard treatment | 0.274055 |
| Hypopharyngeal Cancer Treatment | 0.314822 |
|
CLICK HERE |
| 1664 |
National Cancer Institute |
Html |
en |
Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of childhood atypical teratoid/rhabdoid tumors |
| cancer treatment | 0.542006 |
| metastatic brain tumors | 0.391418 |
| ongoing clinical trials | 0.389415 |
| PDQ cancer information | 0.511527 |
| tumor suppressor genes | 0.452709 |
| clinical trial search | 0.399694 |
| brain tumors | 0.444671 |
| CNS atypical teratoid/rhabdoid | 0.388691 |
| clinical trials | 0.847224 |
| Pediatric Treatment Editorial | 0.416481 |
| Teratoid/Rhabdoid Tumor Treatment | 0.445097 |
| cancer information summary | 0.463674 |
| clinical trial | 0.521041 |
| cancer cells | 0.510172 |
| stem cell transplant | 0.396934 |
| patients | 0.411179 |
| primary brain tumors | 0.3918 |
| treatment clinical trial | 0.409064 |
| NCI PDQ cancer | 0.42324 |
| radiation therapy | 0.555658 |
| Treatment Editorial Board | 0.420841 |
| Cord Tumors Treatment | 0.414346 |
| late effects | 0.393798 |
| treatment | 0.689522 |
| new cancer treatments | 0.395428 |
|
| PDQ treatment summary | 0.447943 |
| childhood brain | 0.385451 |
| Cancer Information Service | 0.399251 |
| specific cancer cells | 0.397642 |
| PDQ Pediatric Treatment | 0.40786 |
| treatment clinical trials | 0.444124 |
| National Cancer Institute | 0.458723 |
| spinal cord | 0.616147 |
| tumor cells | 0.437516 |
| effects cancer treatment | 0.421518 |
| new treatment | 0.427513 |
| childhood cancer information | 0.400212 |
| External radiation therapy | 0.395094 |
| brain tumor | 0.405279 |
| brain | 0.467984 |
| atypical teratoid/rhabdoid tumor | 0.982554 |
| PDQ summary | 0.439127 |
| cancer clinical trials | 0.434177 |
| cancer information summaries | 0.39809 |
| comprehensive cancer information | 0.397631 |
| cancer | 0.740574 |
| appropriate cancer treatment | 0.419383 |
| standard treatment | 0.391688 |
| fast-growing tumor | 0.388774 |
|
CLICK HERE |
| 1825 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de hígado infantil (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento cáncer de hígado infantil. |
| liver tumors | 0.936797 |
| Pediatric Oncology | 0.824708 |
| PRETEXT III | 0.10879 |
| Aronson DC | 0.0851201 |
| results from | 0.266716 |
| Paediatric Oncology | 0.0823629 |
| international pediatric liver | 0.110029 |
| Tumor Study Group | 0.204309 |
| standard-risk hepatoblastoma | 0.125193 |
| childhood liver tumors | 0.0905382 |
| Study Group | 0.298822 |
| Maibach R | 0.0922692 |
| hepatocellular carcinoma | 0.861587 |
| International Society | 0.42048 |
| IV hepatoblastoma | 0.218263 |
| Krailo MD | 0.0915991 |
| cog liver tumors | 0.124853 |
| Children's Oncology Group | 0.248758 |
| Estados Unidos | 0.091099 |
| hepatoblastoma with | 0.740659 |
| pediatric liver tumors | 0.222622 |
| hepatoblastoma after chemotherapy | 0.124744 |
| Pediatric Oncology Liver | 0.123326 |
| childhood hepatoblastoma | 0.552956 |
| with hepatoblastoma | 0.638805 |
|
| Perilongo G | 0.171974 |
| PRETEXT IV | 0.0802866 |
| grupos pretext | 0.174753 |
| Group intergroup study | 0.0861929 |
| Pediatr Blood Cancer | 0.319797 |
| Oncology Group study | 0.119848 |
| childhood liver | 0.102417 |
| Japanese Study Group | 0.0968813 |
| report from | 0.211803 |
| Childrens Cancer Study | 0.0958008 |
| quimioterapia preoperatoria | 0.196007 |
| Hepatoblastoma presenting with | 0.134427 |
| Liver Tumor Study | 0.217304 |
| Pediatr Surg | 0.270609 |
| Clin Oncol | 0.979661 |
| Hepatoblastoma metastatic | 0.11507 |
| Otte JB | 0.0939222 |
| Children's Cancer Group | 0.202883 |
| Shafford E | 0.259892 |
| prospective study | 0.154606 |
| Oncology Liver Tumor | 0.132492 |
| pediatric oncology group | 0.588258 |
| oncology group | 0.803949 |
| Cancer Study Group | 0.108904 |
|
CLICK HERE |
| 1883 |
National Cancer Institute |
Html |
es |
Tratamiento de los tumores extracraneales de células germinativas en la niñez (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento de los tumores extracraneales de células germinativas en la niñez. |
| cell tumor protocols | 0.408279 |
| germinativas malignas localización | 0.405353 |
| células germinativas seminomatosos.Seminoma | 0.410393 |
| cell tumor combined | 0.407867 |
| germ cell tumours | 0.412186 |
| Perlman EJ | 0.405253 |
| Calaminus G | 0.412513 |
| Cell Cancer Collaborative | 0.406794 |
| cell tumors from | 0.406747 |
| Göbel U | 0.406021 |
| Cancer Group | 0.42074 |
| cell tumor studies | 0.407558 |
| pediatric oncology | 0.41388 |
| células germinativas mixtos | 0.417539 |
| International Germ Cell | 0.417008 |
| Children's Oncology Group | 0.409014 |
| mediastinal germ | 0.406328 |
| cell tumor study | 0.408368 |
| <2 cm | 0.405406 |
| Metástasis peritoneales macroscópicas | 0.405941 |
| germ cell neoplasms | 0.406391 |
| Children's Cancer | 0.42175 |
| cell tumors show | 0.406094 |
| pediatric germ | 0.426106 |
| adultos jóvenes | 0.40725 |
|
| estadio iv | 0.405826 |
| ganglios linfáticos ≥2 | 0.411723 |
| Germ Cell Consensus | 0.412507 |
| Cushing B | 0.405386 |
| teratomas benignos | 0.407141 |
| Genes Chromosomes Cancer | 0.438953 |
| with germ | 0.406335 |
| malignant germ cell | 0.462527 |
| PDQ Tratamiento | 0.405882 |
| childhood germ | 0.409831 |
| cell tumors based | 0.405903 |
| Clin Oncol | 0.444548 |
| saco vitelino | 0.435575 |
| linfáticos ≥2 cm | 0.408554 |
| Schneider DT | 0.409517 |
| Children's Cancer Group | 0.419331 |
| Cell Consensus Classification | 0.409901 |
| germ cell tumors | 0.974328 |
| Kingdom Children Cancer | 0.408316 |
| germ cell cancer | 0.410294 |
| Children's Cancer Study | 0.409136 |
| pediatric oncology group | 0.410202 |
| oncology group | 0.420408 |
| Cancer Study Group | 0.411644 |
|
CLICK HERE |
| 1911 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de células renales (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de células renales. |
| siguientes procedimientos | 0.302667 |
| mal uso | 0.302989 |
| siguientes aspectos | 0.301319 |
| estadio ii | 0.309628 |
| túbulos renales | 0.304796 |
| pequeños trozos | 0.300679 |
| siguientes tipos | 0.302146 |
| Renal Cell | 0.303601 |
| rayos x | 0.302568 |
| sistema urinario masculino | 0.3018 |
| enlace drugs approved | 0.306606 |
| riñón sano donado | 0.303031 |
| National Cancer Institute | 0.300453 |
| siguientes riesgos | 0.300391 |
| realidad células | 0.303887 |
|
| pelvis renal | 0.306725 |
| Instituto Nacional | 0.301826 |
| PDQ Tratamiento | 0.304405 |
| Physician Data Query | 0.301827 |
| nefrectomÃa radical | 0.310748 |
| pequeña incisión | 0.300747 |
| tumor mide | 0.303146 |
| von hippel-lindau | 0.30106 |
| vejiga almacena | 0.301249 |
| pequeños túbulos | 0.301281 |
| siguientes enlaces | 0.300545 |
| células renales | 0.988263 |
| riesgo cáncer | 0.31289 |
| siguientes pruebas | 0.301322 |
| vasos sanguÃneos | 0.317262 |
|
CLICK HERE |
| 2000 |
National Cancer Institute |
Html |
es |
Tratamiento de la histiocitosis de células de Langerhans (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento de la histiocitosis de células de Langerhans. |
| cuánto aire | 0.415134 |
| siguientes procedimientos | 0.528715 |
| células madre | 0.858073 |
| adultos jóvenes | 0.464664 |
| efectos secundarios meses | 0.439126 |
| siguientes aspectos | 0.434701 |
| faja ajustadora | 0.428231 |
| HCL infantil multisistémica | 0.546722 |
| cuántos sistemas | 0.518567 |
| genes ras | 0.453948 |
| pequeña cantidad | 0.423844 |
| células normales.ampliar exploración | 0.532323 |
| vÃa oral | 0.42013 |
| rayos x | 0.425227 |
| gen braf | 0.666188 |
| largo plazo | 0.44968 |
| cuántas células | 0.518957 |
| niño ayuda | 0.426203 |
| efectos tardÃos | 0.516221 |
| escáner.ampliar exploración | 0.429231 |
| tarde.ampliar ecografÃa | 0.427113 |
|
| vÃas respiratorias | 0.424871 |
| causa problemas | 0.424997 |
| lesiones óseas | 0.423193 |
| National Cancer Institute | 0.417904 |
| IRMN).Ampliar Imágenes | 0.421648 |
| siguientes riesgos | 0.415861 |
| radiación uvb | 0.414555 |
| Instituto Nacional | 0.431398 |
| PDQ Tratamiento | 0.451873 |
| antecedentes familiares | 0.589915 |
| llamada genes ras | 0.432872 |
| explorador tep | 0.430081 |
| terapia fotodinámica causa | 0.453098 |
| sistema nervioso central | 0.604707 |
| Physician Data Query | 0.464236 |
| mayores probabilidades | 0.416225 |
| HCL multisistémica | 0.966875 |
| terapia fotodinámica llamada | 0.451949 |
| radiación ultravioleta | 0.561342 |
| siguientes pruebas | 0.489919 |
|
CLICK HERE |
| 3432 |
National Cancer Institute |
Html |
es |
Formaldehído y el riesgo de cáncer |
Hoja informativa que trata sobre el formaldehído y su posible relación con el cáncer. Incluye recursos para consultar mayor información. |
| leucemia mieloide | 0.978153 |
| malignancies among workers | 0.549063 |
| TW Alexander Drive | 0.542382 |
| exterior-grade” pressed-wood | 0.527538 |
| cancers among workers | 0.548254 |
| Programa Nacional | 0.567373 |
| largo plazo | 0.580439 |
| Protección Ambiental | 0.673926 |
| Salud Ocupacional | 0.583378 |
| Mortality from | 0.576068 |
| Instituto Nacional | 0.645898 |
| Indoor Air | 0.527731 |
| pequeñas cantidades | 0.52948 |
| Lubin JH | 0.573228 |
| posibles efectos | 0.584035 |
| Estados Unidos | 0.527658 |
| PubMed Abstract | 0.744149 |
| Cancer Institute Cohort | 0.547453 |
| East West Highway | 0.542743 |
| International Agency | 0.53583 |
| Environmental Protection Agency | 0.819165 |
| probable carcinógeno | 0.619447 |
| Product Safety Commission | 0.830336 |
| among workers | 0.572581 |
| New Hampshire Avenue | 0.541693 |
|
| aislamiento uffi | 0.536299 |
| National Toxicology Program | 0.804784 |
| Drug Administration | 0.579636 |
| Environmental Health Sciences | 0.548429 |
| Occupational Environmental Medicine | 0.553867 |
| Mortality among | 0.531703 |
| Occupational Safety | 0.816569 |
| materiales aislantes | 0.528932 |
| British chemical workers | 0.549313 |
| Emergency Management Agency | 0.637566 |
| vÃas respiratorias | 0.526175 |
| National Cancer Institute | 0.733699 |
| National Institute | 0.579158 |
| aislamiento tipo uffi | 0.553887 |
| Health Administration | 0.662185 |
| Consumer Product Safety | 0.833221 |
| Indoor Environments Division | 0.548156 |
| corto plazo | 0.574665 |
| garment workers | 0.530046 |
| Blair A | 0.564637 |
| cabo estudios | 0.530631 |
| 12.º informe | 0.526826 |
| Federal Emergency Management | 0.627002 |
| Institutos Nacionales | 0.577211 |
|
CLICK HERE |
| 4337 |
National Cancer Institute |
Html |
en |
Appetite Loss and Cancer Treatment |
Cancer treatments may lower your appetite. Side effects such as nausea, fatigue, or mouth sores can also making eating difficult. Learn how to eat well to avoid losing weight or becoming dehydrated, so you stay strong during treatment. |
| Care PDQ® summary | 0.905921 |
| questions | 0.493671 |
| liquids | 0.644562 |
| dietitian | 0.466542 |
| short walk | 0.691875 |
| health care team | 0.956003 |
| professional version | 0.683094 |
| variety | 0.451735 |
| causes | 0.450224 |
| nurse | 0.455725 |
| Prepare | 0.451462 |
| dehydration | 0.472596 |
| throat problems | 0.73358 |
| drink choices | 0.682925 |
| vomiting | 0.475861 |
| food tastes | 0.745638 |
| Cancer treatments | 0.729931 |
| cancer patients | 0.671489 |
| supplemental nutrition drinks | 0.886258 |
| weight | 0.457616 |
| large meals | 0.701392 |
| plenty | 0.541422 |
|
| calories | 0.468062 |
| list | 0.493655 |
| eating | 0.456684 |
| steps | 0.457353 |
| people | 0.451814 |
| dangerous condition | 0.706738 |
| small meals | 0.702125 |
| way | 0.460708 |
| nausea | 0.479468 |
| nutritional problems | 0.667746 |
| doctor | 0.457447 |
| symptoms | 0.451468 |
| supplements | 0.451833 |
| Cancer-related fatigue | 0.794241 |
| effects | 0.460377 |
| mouth | 0.464482 |
| vitamins | 0.459091 |
| NCI | 0.456663 |
| high-nutrient foods | 0.702331 |
| appetite | 0.964964 |
| information | 0.45027 |
| nutrient-dense foods | 0.715035 |
|
CLICK HERE |